MML Investors Services’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-54,227
| Closed | -$90K | – | 2511 |
|
|
2023
Q4 | $90K | Hold |
54,227
| – | – | ﹤0.01% | 2392 |
|
|
2023
Q3 | $104K | Hold |
54,227
| – | – | ﹤0.01% | 2240 |
|
|
2023
Q2 | $78K | Sell |
54,227
-550
| -1% | -$791 | ﹤0.01% | 2260 |
|
|
2023
Q1 | $115K | Hold |
54,777
| – | – | ﹤0.01% | 1959 |
|
|
2022
Q4 | $62K | Buy |
54,777
+5,000
| +10% | +$5.66K | ﹤0.01% | 2115 |
|
|
2022
Q3 | $81K | Buy |
49,777
+11,000
| +28% | +$17.9K | ﹤0.01% | 2031 |
|
|
2022
Q2 | $51K | Hold |
38,777
| – | – | ﹤0.01% | 2004 |
|
|
2022
Q1 | $62K | Buy |
38,777
+5,000
| +15% | +$7.99K | ﹤0.01% | 2034 |
|
|
2021
Q4 | $70K | Buy |
33,777
+2,959
| +10% | +$6.13K | ﹤0.01% | 1991 |
|
|
2021
Q3 | $120K | Hold |
30,818
| – | – | ﹤0.01% | 1912 |
|
|
2021
Q2 | $99K | Hold |
30,818
| – | – | ﹤0.01% | 1871 |
|
|
2021
Q1 | $67K | Hold |
30,818
| – | – | ﹤0.01% | 1781 |
|
|
2020
Q4 | $69K | Buy |
30,818
+2,277
| +8% | +$5.1K | ﹤0.01% | 1651 |
|
|
2020
Q3 | $76K | Hold |
28,541
| – | – | ﹤0.01% | 1548 |
|
|
2020
Q2 | $87K | Hold |
28,541
| – | – | ﹤0.01% | 1488 |
|
|
2020
Q1 | $56K | Buy |
28,541
+6,400
| +29% | +$12.6K | ﹤0.01% | 1365 |
|
|
2019
Q4 | $63K | Hold |
22,141
| – | – | ﹤0.01% | 1487 |
|
|
2019
Q3 | $81K | Sell |
22,141
-6,652
| -23% | -$24.3K | ﹤0.01% | 1451 |
|
|
2019
Q2 | $119K | Buy |
28,793
+8,009
| +39% | +$33.1K | ﹤0.01% | 1558 |
|
|
2019
Q1 | $106K | Sell |
20,784
-6,142
| -23% | -$31.3K | ﹤0.01% | 1553 |
|
|
2018
Q4 | $92K | Buy |
26,926
+9,642
| +56% | +$32.9K | ﹤0.01% | 1461 |
|
|
2018
Q3 | $104K | Sell |
17,284
-3,227
| -16% | -$19.4K | ﹤0.01% | 1570 |
|
|
2018
Q2 | $130K | Buy |
20,511
+2,917
| +17% | +$18.5K | ﹤0.01% | 1316 |
|
|
2018
Q1 | $83K | Sell |
17,594
-9,619
| -35% | -$45.4K | ﹤0.01% | 1338 |
|
|
2017
Q4 | $91K | Buy |
27,213
+15,822
| +139% | +$52.9K | ﹤0.01% | 1364 |
|
|
2017
Q3 | $24K | Buy |
+11,391
| New | +$24K | ﹤0.01% | 1309 |
|